Rating and Price Target Roundup: Advanced Micro Devices, Inc. (NASDAQ:AMD), CVS Health Corporation (NYSE:CVS)

June 27, 2017

Advanced Micro Devices, Inc. (NASDAQ:AMD) shares have a current ABR (average broker recommendation) of 2.16. This recommendation is offered by Zacks Research. The rating lands on a sliding numerical scale from 1 to 5. A recommendation of 5 would indicate a Strong Sell, and a 1 would signify a Strong Buy. The mean rating may help provide a general sense of analyst sentiment on company shares.

Sell-side analysts taken into consideration by Zacks have also provided price target estimates on shares of Advanced Micro Devices, Inc. (NASDAQ:AMD). The highest current target is $20. The lowest price target out of the polled analysts is presently $7. The consensus target price is currently noted at $13.538. Analysts may employ various techniques to help predict future stock price levels.

On the earnings front, Advanced Micro Devices, Inc. (NASDAQ:AMD) is expected to post quarterly earnings per share of $-0.02. This is the current consensus figure provided by Zacks. Investors and analysts will be looking for the company to next post earnings on or around 2017-07-20. Advanced Micro Devices, Inc. (NASDAQ:AMD) most recently reported quarterly EPS of $-0.07 for the quarter ending 2017-03-31. The gap between the actual and the projected estimate leading up to earnings created a surprise factor of 0%.

CVS Health Corporation (NYSE:CVS) shares have a current ABR (average broker recommendation) of 1.69. This recommendation is offered by Zacks Research. The rating lands on a sliding numerical scale from 1 to 5. A recommendation of 5 would indicate a Strong Sell, and a 1 would signify a Strong Buy. The mean rating may help provide a general sense of analyst sentiment on company shares.

Sell-side analysts taken into consideration by Zacks have also provided price target estimates on shares of CVS Health Corporation (NYSE:CVS). The highest current target is $96. The lowest price target out of the polled analysts is presently $77. The consensus target price is currently noted at $88.411. Analysts may employ various techniques to help predict future stock price levels.

On the earnings front, CVS Health Corporation (NYSE:CVS) is expected to post quarterly earnings per share of $1.31. This is the current consensus figure provided by Zacks. Investors and analysts will be looking for the company to next post earnings on or around 2017-08-08. CVS Health Corporation (NYSE:CVS) most recently reported quarterly EPS of $1.17 for the quarter ending 2017-03-31. The gap between the actual and the projected estimate leading up to earnings created a surprise factor of 6.36%.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

By DR Staff Writer

Free Email Newsletter


Enter your email address below to get the latest news and analysts' ratings for your stocks with MarketBeat's FREE daily email newsletter:


Latest Stories